BP000136-CYT-682: Recombinant Human IL-13 Variant
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of >1,000,000 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.
Purity > 95%, by SDS--PAGE and RP-HPLC.BP000136-CYT-391: Recombinant Rat IL-13
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000133-CYT-497: Recombinant Mouse Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant co-stimulation with IL-4 of mouse MC-9 cells was found to be < 2 ug/ml, corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000135-CYT-488: Recombinant Human IL-12 p40
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000135-CYT-390: Recombinant Rat IL-12
Source: E. coli-derived.
ED50 range = 0.01-0.05 ug/ml corresponding to a specific activity of 20-100 MIU/mg as determined by the dose dependent secretion of interferon-gamma from PHA and IL-2 activated mouse splenocytes that have been costimulated with PMA. Optimal concentration for individual application should be determined by a dose response assay.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000135-CYT-362: Recombinant Human IL-12
Source: E. coli-derived.
It is recommended to reconstitute the lyophilized Interleukin-12 in sterile 18 M?-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000135-CYT-487: Recombinant Human IL-12 p35
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000134-CYT-013: Recombinant Human Interleukin-11 (IL-11) Protein, Pichia
Source: Pichia Pastoris-derived..
The ED50 as determined by the dose-dependent stimulation of the proliferation of murine 7TD1 was found to be less then 0.2 ug/ml, corresponding to a Specific Activity of1,000,000 IU/ mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000133-CYT-486: Recombinant Human Interleukin-10 (IL-10) Protein, His
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000133-CYT-500: Recombinant Human Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent co-stimulation (with murine IL-4) of MC/9 cells was found to be less than 2.0 ug/ml, corresponding to a specific activity of 5.0?05 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.